BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy

January 30, 2024

https://www.globenewswire.com/news-release/2024/01/30/2820012/22558/en/BioSig-Announces-Cost-Reductions-to-Improve-its-Financial-Standing-and-Shifts-its-Core-Strategy.html


Westport, CT, Jan. 30, 2024 (GLOBE NEWSWIRE) —  BioSig Technologies, Inc. (NASDAQ:BSGM) (“BioSig” or the “Company”), a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced a workforce reduction, intended to reduce annual cash burn by 50%.  The Company is reducing its internal workforce, which is expected to be completed by January 31. The Company is also shifting its business model and seeks to partner with organizations for sales distribution and clinical support of its PURE EP™ Platform.

Read more at globenewswire.com

Related news for (BSGM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.